Fact CheckerSign in

NCT06626022RecruitingPhase 3

Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging.

A Phase 3, Multicenter, International, Non-inferiority, Randomized Clinical Trial Comparing Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging (MUSIC-Screen)

Source: ClinicalTrials.gov · Last updated 25 Sept 2026

Brief summary (registry, in English)

The purpose of this study is to compare whether the FDA and Health Canada approved microUS is as effective as the currently used option (MRI) for imaging the prostate gland. Participants will be randomized into two groups to compare the imaging results of the current standard of care MRI and the new microUS. The study is looking to identify the most effective imaging modality to help guide whether you progress to have a prostate biopsy.

Status (registry)
Recruiting
Phase (registry)
Phase 3
Study type
Interventional
Enrollment
1284 (estimated)
First submitted
1 Oct 2024
Start date
8 May 2025
Primary completion date
30 Nov 2029
Lead sponsor
University of Alberta
NCT number
NCT06626022

What you commit to

  • Study type: Interventional · Phase 3
  • Planned participants: 1284
  • From 8 May 2025 to the primary completion date, 30 Nov 2029
  • 9 sites in 5 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Prior personal history of prostate cancer;
  • Prior prostate imaging using microUS or MRI;
  • Testosterone replacement therapy within last 12 months; or
  • Androgen deprivation therapy within last 12 months.

Other

  • Contraindication to microUS or MRI;

Who the study is looking for

  • Male sex;
  • Age 50-70;
  • PSA 3-20 and/or abnormal DRE;
  • Biopsy naïve.

Age in the registry: 50 years to 70 years · Sex: Male · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (9)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Alberta
Coordinator of this site? Confirm its status
EdmontonCanadaActive, not recruiting
CIUSSS du Nord-de-L'Ile-De-Montreal
Coordinator of this site? Confirm its status
MontrealCanadaNot yet recruiting
Sunnybrook Health Sciences Centre
Coordinator of this site? Confirm its status
TorontoCanadaRecruiting
University of British Columbia
Coordinator of this site? Confirm its status
VancouverCanadaRecruiting
Urologia Clinica Bilbao
Coordinator of this site? Confirm its status
BilbaoSpainRecruiting
CH de Martigues
Coordinator of this site? Confirm its status
MartiguesFranceRecruiting
Vestfold Hospital Trust
Coordinator of this site? Confirm its status
TønsbergNorwayRecruiting
UT Southwestern Medical Center
Coordinator of this site? Confirm its status
DallasUnited StatesNot yet recruiting
University of California Los Angeles (UCLA).
Coordinator of this site? Confirm its status
Los AngelesUnited StatesRecruiting

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.